D. Srivastava

Efficacy of inactivated H5N2 influenza vaccines against lethal A/Chicken/Queretaro/19/95 infection.

R. Webster, D. Jayawardene, A. García, 1998, Avian diseases.

Changes in acute encephalitis syndrome incidence after introduction of Japanese encephalitis vaccine in a region of India.

M. Gore, M. Murhekar, S. Selvaraju, 2014, The Journal of infection.

Epidemiological evaluation of BCG vaccine efficacy in Delhi--1989.

K. K. Datta, R. Sharma, D. Mullick, 1989, The Journal of communicable diseases.

Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics

A. Thacker, N. Sarkari, D. Srivastava, 2011, Journal of Neurology.

Japanese encephalitis (JE) part II: 14 Years’ follow-up of survivors

A. Thacker, N. Sarkari, D. Srivastava, 2011, Journal of Neurology.

Global Scenario of Antiviral Drugs for Japanese Encephalitis

D. Srivastava, 2016 .

A REVIEW ON THE COVID-19 (NOVEL CORONAVIRUS) CHARACTERISTICS, EVALUATION, AND TREATMENT

D. Srivastava, Vikram Srivastava, H. Awasthi, 2020 .

Decline in Japanese Encephalitis, Kushinagar District, Uttar Pradesh, India

M. Gore, M. Murhekar, S. Selvaraju, 2014, Emerging Infectious Diseases.